Last reviewed · How we verify
PICOPREP
At a glance
| Generic name | PICOPREP |
|---|---|
| Also known as | PicoPrep™, Prepopik™ |
| Sponsor | Ferring Pharmaceuticals |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy (PHASE3)
- Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PHASE1,PHASE2)
- Comparing the Bowel Cleansing Efcacy of Picosulfate Sodium/ Citric Acid / Magnesium Oxide and Polyethylene Glycol: A Randomized Trial in Taiwan (NA)
- The Effect of Video-Based Education on Colonoscopy Preparation (NA)
- PEG-Asc Vs. SPMC for Bowel Preparation in Capsule-based Procedures (NA)
- Efficacy, Tolerance and Safety of Split Dose Bowel Preparation for Colonoscopy: 4L Polyethylene Glycol (PEG) Versus 1L Polyethylene Glycol Plus Sodium Picosulfate-magnesium Citrate (SPMC) (PHASE4)
- Validation of a Prediction Model for Inadequate Bowel Preparation
- Bowel Cleansing Performance of the Pure-Vu System in Patients With a History of Poor Bowel Preparation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PICOPREP CI brief — competitive landscape report
- PICOPREP updates RSS · CI watch RSS
- Ferring Pharmaceuticals portfolio CI